Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1994-10-03
1997-07-01
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 3116
Patent
active
056439660
ABSTRACT:
.beta.-alethine is identified as an anti-tumor agent.
REFERENCES:
patent: 2835704 (1958-05-01), Walton
patent: 4552765 (1985-11-01), Mita et al.
patent: 5013546 (1991-05-01), Gottlieb et al.
Oiry et al, "Synthesis and Radioprotective Activity of New Cysteamine and Cystamine Derivatives", J. Med. Chem. 29(11):2217-2225 (1986).
Komoriya et al, "Anti-Arthritic and Immunoregulatory Effects of T1-31 on Collagen-Induced Arthritis", Japan. J. Pharmacol. 45:389-396 (1987).
Komoriya et al, "Inhibitory effect of T1-31 on autoimmune nephritis in B/NZW F.sub.1 mice through regulation of the immune response", Immunopharmacology 13:89-98 (1987).
Waldmann, "Monoclonal Antibodies in Diagnosis and Therapy", Science 252:1657-1662 (1991).
Roederer et al, "Cytokine-Stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine", Proc. Natl. Acad. Sci. USA 87:4884-4888 (1990).
Foon, "Biological Response Modifiers: The New Immunotherapy", Cancer Research 49:1621-1639 (1989).
Osband et al, "Problems in the investigational study and clinical use of cancer immunotherapy", Immunology Today 11(6):193-195 (1990).
Immunology Second Edition, edited by Jean-Francois Bach, M.D., D.Sc., pp. 88-105.
Stalb et al., "Protection against experimental Cerebral Metastases of Murine Melanoma B16 by Active Immunization", Cancer Research 53:1113-1121 (1993).
Current Protocols in Immunology, edited by John E. Coligan (1991).
Sachs, "Growth, Differentiation and the Reversal of Malignancy", Scientific American, pp. 40-47 (1986).
Cockroft, "Nutrient requirements of rat embryos undergoing organogenesis in vitro", J. Reprod. Fert. 57:505-510 (1979).
Droge et al, "Modulation of Lymphocyte Functions and Immune Responses by Cysteine and Cysteine Derivatives", The American Journal of Medicine 91 (suppl 3C):3C-140S (1991).
Knight Galen D.
Mann Paul L.
Scallen Terrance J.
Goldberg Jerome D.
University of New Mexico
LandOfFree
.beta.-alethine as anti-tumor agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-alethine as anti-tumor agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-alethine as anti-tumor agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597864